about
Disruption of Bcl-2 and Bcl-xL by viral proteins as a possible cause of cancerHuman cytomegalovirus infection in tumor cells of the nervous system is not detectable with standardized pathologico-virological diagnostics.PUL21a-Cyclin A2 interaction is required to protect human cytomegalovirus-infected cells from the deleterious consequences of mitotic entry.Human cytomegalovirus pUL79 is an elongation factor of RNA polymerase II for viral gene transcription.Discordant humoral and cellular immune responses to Cytomegalovirus (CMV) in glioblastoma patients whose tumors are positive for CMV.Human cytomegalovirus gene expression in long-term infected glioma stem cells.Increased Viral Dissemination in the Brain and Lethality in MCMV-Infected, Dicer-Deficient NeonatesHuman Cytomegalovirus in Oral Squamous Cell Carcinoma in Southeast of Iran.The cytomegalovirus protein UL138 induces apoptosis of gastric cancer cells by binding to heat shock protein 70.No evidence of association between human cytomegalovirus infection and papillary thyroid cancer.Use of in vivo imaging to monitor the progression of experimental mouse cytomegalovirus infection in neonates.Increased incidence of cytomegalovirus coinfection in HCV-infected patients with late liver fibrosis is associated with dysregulation of JAK-STAT pathway.Ganciclovir concentrations in the cerebral extracellular space after valganciclovir treatment; a case study.Does the existence of HCMV components predict poor prognosis in glioma?HHV-6 antigen and HHV-6 DNA expression in sporadic adenomatous polyps of the colon.Cytomegalovirus infection in brain tumors: A potential new target for therapy?Immunosuppressants in cancer prevention and therapyAbsence of Epstein-Barr and cytomegalovirus infection in neuroblastoma cells by standard detection methodologies.Characterization of cytomegalovirus and epstein-barr virus infection in cervical lesions in Portugal.Almost Complete Lack of Human Cytomegalovirus and Human papillomaviruses Genome in Benign and Malignant Breast Lesions in Shiraz, Southwest of IranThe Human Cytomegalovirus, from Oncomodulation to Oncogenesis
P2860
Q27020978-D7059D5D-33CB-4B3F-8A22-11D62A6CF578Q34359722-B77D4D72-30F1-43F1-AB25-49024D2413DCQ34506903-43EA7670-FD1A-49A0-AD5C-0DE944FFACB1Q35233593-13C9E550-F394-483E-A982-81474C8A4585Q35506920-7774F2CE-5DA6-43E8-929E-AF7C7DCF34DEQ35535809-0669EA9A-31E5-4E78-8A26-7B632CCFD339Q35675999-E9D61E6D-A57D-4524-896F-F3901AB9B7D9Q36144023-BEC131B8-E0DE-4E6D-9F05-4C2B4579C1C9Q36905736-584DF25A-4396-467C-992B-BBC03615F309Q37717311-848928BD-902D-4EFE-9826-26529FB5EF7CQ39385216-3292D5F8-6FD7-4AA0-9BE9-3DE125A3FB74Q40058226-0B0563D3-31AC-494C-8052-F7B4D026212AQ40869992-1084C7E3-DDE7-43DF-AC2F-923FE6F16A66Q42244894-B21CCE73-10F4-49E1-8124-21548EEEEC3DQ42264425-49AE338F-7291-498F-912A-3EF967CA36F3Q42321647-06D4A998-70CC-4A34-8831-561534C6C3C9Q42505783-C5E2A622-6D71-4DA2-A53A-8D712A385E56Q43561288-9829955A-0177-4822-AD9B-CA3E69B2EC85Q45350755-DD24E181-B53B-44F5-937E-968481A33101Q47559779-88BD221A-44C6-405E-869A-4FE3D08EF030Q58801069-B16F7889-E233-4DEE-BEE5-653DC9C0E290
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Is human cytomegalovirus a target in cancer therapy?
@en
Is human cytomegalovirus a target in cancer therapy?
@nl
type
label
Is human cytomegalovirus a target in cancer therapy?
@en
Is human cytomegalovirus a target in cancer therapy?
@nl
prefLabel
Is human cytomegalovirus a target in cancer therapy?
@en
Is human cytomegalovirus a target in cancer therapy?
@nl
P2860
P921
P356
P1433
P1476
Is human cytomegalovirus a target in cancer therapy?
@en
P2093
John Inge Johnsen
Ninib Baryawno
P2860
P304
P356
10.18632/ONCOTARGET.383
P407
P5008
P577
2011-12-01T00:00:00Z